Evidence map›Paper›PMID 41775700›Full record

ArticleTranslational psychiatry2026

Maternal immune activation with high molecular weight poly (I:C) induces selective depressive-like phenotype in adult offspring.

Michele Santoni, Andrea Mastio, Luca Concas, Rafaela Mostallino, Anna Herres, Claudia Sagheddu, M Paola Castelli, Roberto Frau, Anna Lisa Muntoni, Marco Pistis

Abstract read
In one paragraph

Article in Translational psychiatry, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Michele SantoniDivision of Neuroscience and Clinical Pharmacology, Department of Biomedical Sciences, University of Cagliari, 09042, Cagliari, Monserrato, Italy.ORCID http://orcid.org/0000-0003-4603-2369
Andrea MastioDivision of Neuroscience and Clinical Pharmacology, Department of Biomedical Sciences, University of Cagliari, 09042, Cagliari, Monserrato, Italy.
Luca ConcasDivision of Neuroscience and Clinical Pharmacology, Department of Biomedical Sciences, University of Cagliari, 09042, Cagliari, Monserrato, Italy.ORCID http://orcid.org/0000-0002-2921-3128
Rafaela MostallinoDivision of Neuroscience and Clinical Pharmacology, Department of Biomedical Sciences, University of Cagliari, 09042, Cagliari, Monserrato, Italy.
Anna HerresDivision of Neuroscience and Clinical Pharmacology, Department of Biomedical Sciences, University of Cagliari, 09042, Cagliari, Monserrato, Italy.
Claudia SaghedduDivision of Neuroscience and Clinical Pharmacology, Department of Biomedical Sciences, University of Cagliari, 09042, Cagliari, Monserrato, Italy.
M Paola CastelliDivision of Neuroscience and Clinical Pharmacology, Department of Biomedical Sciences, University of Cagliari, 09042, Cagliari, Monserrato, Italy.
Roberto FrauDivision of Neuroscience and Clinical Pharmacology, Department of Biomedical Sciences, University of Cagliari, 09042, Cagliari, Monserrato, Italy.
Anna Lisa MuntoniNeuroscience Institute, Section of Cagliari, National Research Council of Italy (CNR), 09042, Cagliari, Monserrato, Italy.
Marco PistisDivision of Neuroscience and Clinical Pharmacology, Department of Biomedical Sciences, University of Cagliari, 09042, Cagliari, Monserrato, Italy. mpistis@unica.it.ORCID http://orcid.org/0000-0002-4622-3205

Funding

Ministero della Salute (Ministry of Health, Italy) T4-AN-10Ministero dell'Istruzione, dell'Università e della Ricerca (Ministry of Education, University and Research) PRIN 2022 2022NSLB3ZMinistero dell'Istruzione, dell'Università e della Ricerca (Ministry of Education, University and Research) PRIN 2022 P20229CCLBRegione Autonoma della Sardegna (Sardinia Region) PNRR-MAD-2022-12375802
6 · The paper itself

Abstract

Maternal immune activation (MIA) during pregnancy may increase the risk for neurodevelopmental disorders such as schizophrenia and autism in offspring. Preclinical and human evidence support a potential role for MIA in the development of depressive symptoms in offspring. Among animal models of MIA, prenatal treatment with the synthetic viral mimetic polyinosinic-polycytidylic acid [poly (I:C)] is well established in studying psychotic-like and autism-like phenotypes, while its validity for modeling depressive-like behaviors remains underexplored. In this study, we assessed whether MIA, induced in rats with an injection of high molecular weight (HMW) poly (I:C), at gestational day 15, leads to a depressive-like phenotype in the offspring. In male and female offspring during adolescence and adulthood, we evaluated i) behavioral despair and anhedonia using the forced swim test (FST) and sucrose preference test (SPT); ii) the electrophysiological properties of dorsal raphe nucleus (DRN) serotonin (5-HT) neurons in vivo; iii) serum cytokine profile. We found that MIA offspring exhibited increased immobility and reduced climbing and swimming in the FST, with more pronounced effects in males, while sucrose preference remained unaltered. In vivo recordings revealed a significant increase in 5-HT neuron firing rate in MIA adult males. Peripheral cytokine analysis showed elevated IL-1α in MIA males and decreased GRO/KC levels in MIA females. In conclusion, these findings indicate that prenatal exposure to HMW poly (I:C) selectively affects stress-coping mechanisms without inducing anhedonia, modulates serotonergic signaling in a sex- dependent manner in the absence of widespread inflammatory alterations.

Indexed as

Behavior, AnimalDepressionPoly I-CPrenatal Exposure Delayed EffectsAnimalsCytokinesDisease Models, AnimalFemaleMalePhenotypePregnancyRatsCytokinesPoly I-C

Identifiers

PMID41775700
PMCPMC12982799

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.